2021 - Fluorescent- and tagged-protoxin II peptides: potent markers of the Nav1.7 channel pain target

icon sp96SyncroPatch 384PE (a predecessor model of the SyncroPatch 384 instrument) Publication in British Journal of Pharmacological (2021)

Montnach J., De Waard S., Nicolas S., Burel S., Osorio N., Zoukimian C., Mantegazza M., Boukaiba R., Béroud R., Partiseti M., Delmas P., Marionneau C., De Waard M.

British Journal of Pharmacological (2021) doi:10.1111/bph.15453


Protoxin II (ProTx II) is a high affinity gating modifier that is thought to selectively block the Nav1.7 voltage-dependent Na+ channel, a major therapeutic target for the control of pain. We aimed at producing ProTx II analogues entitled with novel functionalities for cell distribution studies and biochemical characterization of its Nav channel targets.

Download here

Back to Overview


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.